681 lines
22 KiB
HTML
681 lines
22 KiB
HTML
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
|
|
<html xmlns="http://www.w3.org/1999/xhtml" lang="en">
|
|
|
|
<head>
|
|
<meta http-equiv="X-UA-Compatible" content="IE=edge">
|
|
<meta name="twitter:card" content="summary_large_image">
|
|
<meta name="twitter:site" content="@NLM_NIH">
|
|
<meta name="twitter:title" content="MEDLINE Data Changes — 2011: Revised Entry Combinations Table. NLM Technical Bulletin. 2010 Nov–Dec">
|
|
<meta name="twitter:description" content=" The NLM Technical Bulletin is your source to stay informed about NLM products and services.">
|
|
<meta name="twitter:image" content="https://www.nlm.nih.gov/pubs/techbull/images/nlm_tech_bulletin_graphic_twitter.jpg">
|
|
<meta property="og:url" content="https://www.nlm.nih.gov/pubs/techbull/tb.html" />
|
|
<meta property="og:type" content="article" />
|
|
<meta property="og:title" content="MEDLINE Data Changes — 2011: Revised Entry Combinations Table. NLM Technical Bulletin. 2010 Nov–Dec" />
|
|
<meta property="og:description" content="The NLM Technical Bulletin is your source to stay informed about NLM products and services." />
|
|
<meta property="og:image" content="https://www.nlm.nih.gov/pubs/techbull/images/nlm_tech_bulletin_graphic_facebook.jpg" />
|
|
<title>MEDLINE Data Changes — 2011: Revised Entry Combinations Table. NLM Technical Bulletin. 2010 Nov–Dec</title>
|
|
<link rel="schema.DC" href="http://purl.org/dc/elements/1.1/" title="The Dublin Core metadata Element Set" />
|
|
<meta name="DC.Title" content="Revised Entry Combinations Table — 2011" />
|
|
|
|
<meta name="DC.Publisher" content="U.S. National Library of Medicine" />
|
|
<meta name="DC.Date.Issued" content="2010-12-02" />
|
|
<meta name="DC.Date.Modified" content="2010-12-02" />
|
|
<meta name="NLMDC.Date.LastReviewed" content="2010-12-02" />
|
|
<meta name="NLM.Contact.Email" content="nlmtechbull@mail.nlm.nih.gov" />
|
|
<meta name="DC.Type" content="Newsletters" />
|
|
<meta name="NLM.Permanence.Level" content="Permanent: Stable Content" />
|
|
<meta name="NLM.Permanence.Guarantor" content="U.S. National Library of Medicine" />
|
|
<meta name="DC.Rights" content="Public Domain" />
|
|
<meta name="DC.Language" content="eng" />
|
|
|
|
|
|
<meta name="DC.Subject.Keyword" content="Entry Combination" />
|
|
<meta name="DC.Subject.Keyword" content="Medical Subject Headings" />
|
|
<meta name="DC.Subject.Keyword" content="MEDLINE" />
|
|
<meta name="DC.Subject.Keyword" content="Nucleotide" />
|
|
<meta name="DC.Subject.Keyword" content="Subheading" />
|
|
<meta name="DC.Subject.Keyword" content="Update" />
|
|
|
|
|
|
<link rel="stylesheet" href="../techBull.css" />
|
|
<link rel="alternate" type="application/rss+xml" title="RSS" href="/rss/techbull.rss" />
|
|
|
|
<!-- Google Tag Manager -->
|
|
<script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='//www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-MT6MLL');</script>
|
|
<!-- End Google Tag Manager -->
|
|
</head>
|
|
<body link="#476B47" alink="#476B47" vlink="#476B47" text="#000000" bgcolor="#ffffff">
|
|
<!-- Google Tag Manager -->
|
|
<noscript><iframe src="//www.googletagmanager.com/ns.html?id=GTM-MT6MLL" height="0" width="0" style="display:none;visibility:hidden" title="googletagmanager"></iframe></noscript>
|
|
<!-- End Google Tag Manager -->
|
|
<div id="skip"><a href="#skipnav">Skip to Main Content</a></div>
|
|
<a name="top" id="top"></a>
|
|
<div id="body" >
|
|
|
|
<div class="header">
|
|
<div class="shadow_bottom" align="left">
|
|
<div class="shadow_right">
|
|
<div class="shadow_corner">
|
|
<table class="title" width="100%" border="0" cellpadding="0" cellspacing="0" >
|
|
<col width="134" />
|
|
<col/>
|
|
<tr>
|
|
<td>
|
|
<img src="../new_tb_graphics/tb_header_logo.gif" alt="" width="134" height="64" align="top" />
|
|
</td>
|
|
<td id="titleCell">
|
|
<img id="titleImage" src="../new_tb_graphics/tb_header_title.gif" alt="NLM Technical Bulletin"
|
|
title="" align="top" border="0" height="26" width="335"/>
|
|
<div id="titleText">NLM Technical Bulletin</div>
|
|
|
|
<div>
|
|
<a href="//www.nlm.nih.gov/">National Library of Medicine</a> |
|
|
<a href="//www.nih.gov/">National Institutes of Health</a>
|
|
</div>
|
|
</td>
|
|
</tr></table>
|
|
</div></div></div></div>
|
|
|
|
<div class="header">
|
|
<div class="shadow_bottom" align="left">
|
|
<div class="shadow_right">
|
|
<div class="shadow_corner">
|
|
<table class="grid" width="100%" border="0" cellpadding="0" cellspacing="0">
|
|
<tr class="search" >
|
|
<td colspan="5" align="right">
|
|
<form method="get" action="//vsearch.nlm.nih.gov/vivisimo/cgi-bin/query-meta" target="_self" name="searchForm">
|
|
<label for="searchInput">Search</label>
|
|
<input name="query" type="text" id="searchInput" size="12" align="middle"/>
|
|
<input type="submit" id="searchGo" value="GO" />
|
|
<input type="hidden" name="v:project" value="technical-bulletin" />
|
|
<a href="/vsearchfaq.html">Help</a>
|
|
</form>
|
|
|
|
<img src="../new_tb_graphics/spacer.gif" width="10" height="1" border="0" alt="" />
|
|
</td>
|
|
</tr>
|
|
<tr align="center">
|
|
<td><a href="nd10_issue_cover.html">Table of Contents</a></td>
|
|
<td><a href="../rss.html" class="rssMenuCover">RSS</a></td>
|
|
<td><a href="../tb.html" class="homeMenuCover">Home</a></td>
|
|
<td><a href="../back_issues.html" class="issuesMenuCover">Back Issues</a></td>
|
|
<td><a href="../new_index.html" class="indexMenuCover">Indexes</a></td>
|
|
</tr>
|
|
<tr>
|
|
<td colspan="5"><span class="issueDateMenu" >2010 NOVEMBER–DECEMBER</span> <span class="issueNum">No. 377</span>
|
|
</td>
|
|
</tr>
|
|
</table>
|
|
</div></div></div></div>
|
|
|
|
<!-- header_end-->
|
|
|
|
|
|
<a name="skipnav" id="skipnav"></a>
|
|
<div id="content" class="article">
|
|
|
|
<div class="actions">December 02, 2010 <span class="status">[posted]</span>
|
|
|
|
|
|
|
|
</div>
|
|
|
|
|
|
|
|
<h1>Revised Entry Combinations Table — 2011</h1>
|
|
|
|
<a href="/pubs/techbull/nd10/nd10_medline_data_changes_2011.html">Return to <em>MEDLINE<span class="registered">®</span> Data Changes — 2011</em> article</a>.
|
|
|
|
<br />
|
|
<br />
|
|
|
|
<table width="727" border="1" cellspacing="0" cellpadding="0" summary="Previous MeSH Heading/Subheading
|
|
(Entry Combination) and the Replaced-by Heading for 2011.
|
|
">
|
|
<tr>
|
|
<th width="440" scope="col"><p align="center"><strong>Previous MeSH Heading/Subheading</strong><br />
|
|
<strong>(Entry Combination)</strong></p></th>
|
|
<th width="281" scope="col"><p align="center"><strong>Replaced-by Heading for 2011</strong></p></th>
|
|
</tr>
|
|
<tr>
|
|
<td><p>3-Oxo-5-alpha-Steroid 4-Dehydrogenase/antagonists & inhibitors</p></td>
|
|
<td><p>5-alpha Reductase Inhibitors</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>5-Lipoxygenase-Activating Proteins/antagonists & inhibitors</p></td>
|
|
<td><p>5-Lipoxygenase-Activating Protein Inhibitors</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Adenosine Deaminase/antagonists & inhibitors</p></td>
|
|
<td><p>Adenosine Deaminase Inhibitors</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Arachidonate 12-Lipoxygenase/antagonists & inhibitors</p></td>
|
|
<td><p>Lipoxygenase Inhibitors</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Arachidonate 15-Lipoxygenase/antagonists & inhibitors</p></td>
|
|
<td><p>Lipoxygenase Inhibitors</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Arachidonate 5-Lipoxygenase/antagonists & inhibitors</p></td>
|
|
<td><p>Lipoxygenase Inhibitors</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>ATP-Binding Cassette Transporters/deficiency</p></td>
|
|
<td><p>Adrenoleukodystrophy</p></td>
|
|
</tr>
|
|
|
|
<tr>
|
|
<td><p>Cardiac Resynchronization Therapy/instrumentation</p></td>
|
|
<td><p>Cardiac Resynchronization Therapy Devices</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Cyclic Nucleotide Phosphodiesterases, Type 3/antagonists & inhibitors</p></td>
|
|
<td><p>Phosphodiesterase 3 Inhibitors</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Cyclic Nucleotide Phosphodiesterases, Type 4/antagonists & inhibitors</p></td>
|
|
<td><p>Phosphodiesterase 4 Inhibitors</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Cyclic Nucleotide Phosphodiesterases, Type 5/antagonists & inhibitors</p></td>
|
|
<td><p>Phosphodiesterase 5 Inhibitors</p></td>
|
|
</tr>
|
|
|
|
<tr>
|
|
<td><p>Dipeptidyl Peptidase 4/antagonists & inhibitors</p></td>
|
|
<td><p>Dipeptidyl-Peptidase IV Inhibitors</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>DNA Topoisomerases/antagonists & inhibitors</p></td>
|
|
<td><p>Topoisomerase Inhibitors</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>DNA Topoisomerases, Type I/antagonists & inhibitors</p></td>
|
|
<td><p>Topoisomerase I Inhibitors</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>DNA Topoisomerases, Type II/antagonists & inhibitors</p></td>
|
|
<td><p>Topoisomerase II Inhibitors</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Factor VIIIa/deficiency</p></td>
|
|
<td><p>Hemophilia A</p></td>
|
|
</tr>
|
|
|
|
<tr>
|
|
<td><p>GABA Plasma Membrane Transport Proteins/antagonists & inhibitors</p></td>
|
|
<td><p>GABA Uptake Inhibitors</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Health Facilities/organization & administration</p></td>
|
|
<td><p>Health Facility Administration</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Lipoxygenases/antagonists & inhibitors</p></td>
|
|
<td><p>Lipoxygenase Inhibitors</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Receptor, Adenosine A1/agonists</p></td>
|
|
<td><p>Adenosine A1 Receptor Agonists</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Receptor, Adenosine A1/antagonists & inhibitors</p></td>
|
|
<td><p>Adenosine A1 Receptor Antagonists</p></td>
|
|
</tr>
|
|
|
|
<tr>
|
|
<td><p>Receptor, Adenosine A2A/agonists</p></td>
|
|
<td><p>Adenosine A2 Receptor Agonists</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Receptor, Adenosine A2A/antagonists & inhibitors</p></td>
|
|
<td><p>Adenosine A2 Receptor Antagonists</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Receptor, Adenosine A2B/agonists</p></td>
|
|
<td><p>Adenosine A2 Receptor Agonists</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Receptor, Adenosine A2B/antagonists & inhibitors</p></td>
|
|
<td><p>Adenosine A2 Receptor Antagonists</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Receptor, Adenosine A3/agonists</p></td>
|
|
<td><p>Adenosine A3 Receptor Agonists</p></td>
|
|
</tr>
|
|
|
|
<tr>
|
|
<td><p>Receptor, Adenosine A3/antagonists & inhibitors</p></td>
|
|
<td><p>Adenosine A3 Receptor Antagonists</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Receptor, Angiotensin, Type 2/antagonists & inhibitors</p></td>
|
|
<td><p>Angiotensin II Type 2 Receptor Blockers</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Receptor, Serotonin,5-HT1A/agonists</p></td>
|
|
<td><p>Serotonin 5-HT1 Receptor Agonists</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Receptor, Serotonin, 5-HT1A/antagonists & inhibitors</p></td>
|
|
<td><p>Serotonin 5-HT1 Receptor Antagonists</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Receptor, Serotonin, 5-HT1B/agonists</p></td>
|
|
<td><p>Serotonin 5-HT1 Receptor Agonists</p></td>
|
|
</tr>
|
|
|
|
<tr>
|
|
<td><p>Receptor, Serotonin, 5-HT1B/antagonists & inhibitors</p></td>
|
|
<td><p>Serotonin 5-HT1 Receptor Antagonists</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Receptor, Serotonin, 5-HT1D/agonists</p></td>
|
|
<td><p>Serotonin 5-HT1 Receptor Agonists</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Receptor, Serotonin, 5-HT1D/antagonists & inhibitors</p></td>
|
|
<td><p>Serotonin 5-HT1 Receptor Antagonists</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Receptor, Serotonin, 5-HT2A/agonists</p></td>
|
|
<td><p>Serotonin 5-HT2 Receptor Agonists</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Receptor, Serotonin, 5-HT2A/antagonists & inhibitors</p></td>
|
|
<td><p>Serotonin 5-HT2 Receptor Antagonists</p></td>
|
|
</tr>
|
|
|
|
<tr>
|
|
<td><p>Receptor, Serotonin,5-HT2B/agonists</p></td>
|
|
<td><p>Serotonin 5-HT2 Receptor Agonists</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Receptor, Serotonin, 5-HT2B/antagonists & inhibitors</p></td>
|
|
<td><p>Serotonin 5-HT2 Receptor Antagonists</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Receptor, Serotonin, 5-HT2C/agonists</p></td>
|
|
<td><p>Serotonin 5-HT2 Receptor Agonists</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Receptor, Serotonin, 5-HT2C/antagonists & inhibitors</p></td>
|
|
<td><p>Serotonin 5-HT2 Receptor Antagonists</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Receptors, Adenosine A2/agonists</p></td>
|
|
<td><p>Adenosine A2 Receptor Agonists</p></td>
|
|
</tr>
|
|
|
|
<tr>
|
|
<td><p>Receptors, Adenosine A2/antagonists & inhibitors</p></td>
|
|
<td><p>Adenosine A2 Receptor Antagonists</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Receptors, Adrenergic, alpha-1/agonists</p></td>
|
|
<td><p>Adrenergic alpha-1 Receptor Agonists</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Receptors, Adrenergic, alpha-1 /antagonists & inhibitors</p></td>
|
|
<td><p>Adrenergic alpha-1 Receptor Antagonists</p></td>
|
|
</tr>
|
|
|
|
<tr>
|
|
<td><p>Receptors, Adrenergic, alpha-2/agonists</p></td>
|
|
<td><p>Adrenergic alpha-2 Receptor Agonists</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Receptors, Adrenergic, alpha-2/antagonists & inhibitors</p></td>
|
|
<td><p>Adrenergic alpha-2 Receptor Antagonists</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Receptors, Adrenergic, beta-1/agonists</p></td>
|
|
<td><p>Adrenergic beta-1 Receptor Agonists</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Receptors, Adrenergic, beta-1/antagonists & inhibitors</p></td>
|
|
<td><p>Adrenergic beta-1 Receptor Antagonists</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Receptors, Adrenergic, beta-2/agonists</p></td>
|
|
<td><p>Adrenergic beta-2 Receptor Agonists</p></td>
|
|
</tr>
|
|
|
|
<tr>
|
|
<td><p>Receptors, Adrenergic, beta-2/antagonists & inhibitors</p></td>
|
|
<td><p>Adrenergic beta-2 Receptor Antagonists</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Receptors, Adrenergic, beta-3/agonists</p></td>
|
|
<td><p>Adrenergic beta-3 Receptor Agonists</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Receptors, Adrenergic, beta-3/antagonists & inhibitors</p></td>
|
|
<td><p>Adrenergic beta-3 Receptor Antagonists</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Receptors, Androgen/agonists</p></td>
|
|
<td><p>Androgens</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Receptors, Androgen/antagonists & inhibitors</p></td>
|
|
<td><p>Androgen Receptor Antagonists</p></td>
|
|
</tr>
|
|
|
|
<tr>
|
|
<td><p>Receptors, Angiotensin/antagonists & inhibitors</p></td>
|
|
<td><p>Angiotensin ReceptorAntagonists</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Receptors, GABA-A/agonists</p></td>
|
|
<td><p>GABA-A Receptor Agonists</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Receptors, GABA-A/antagonists & inhibitors</p></td>
|
|
<td><p>GABA-A Receptor Antagonists</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Receptors, GABA-B/agonists</p></td>
|
|
<td><p>GABA-B Receptor Agonists</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Receptors, GABA-B/antagonists & inhibitors</p></td>
|
|
<td><p>GABA-B Receptor Antagonists</p></td>
|
|
</tr>
|
|
|
|
<tr>
|
|
<td><p>Receptors, Purinergic /agonists</p></td>
|
|
<td><p>Purinergic Agonists</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Receptors, Purinergic/antagonists & inhibitors</p></td>
|
|
<td><p>Purinergic Antagonists</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Receptors, Purinergic P1/agonists</p></td>
|
|
<td><p>Purinergic P1 Receptor Agonists</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Receptors, Purinergic P1/antagonists & inhibitors</p></td>
|
|
<td><p>Purinergic P1 Receptor Antagonists</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Receptors, Purinergic P2/agonists</p></td>
|
|
<td><p>Purinergic P2 Receptor Agonists</p></td>
|
|
</tr>
|
|
|
|
<tr>
|
|
<td><p>Receptors, Purinergic P2/antagonists & inhibitors</p></td>
|
|
<td><p>Purinergic P2 Receptor Antagonists</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Receptors, Purinergic P2X/agonists</p></td>
|
|
<td><p>Purinergic P2X Receptor Agonists</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Receptors, Purinergic P2X/antagonists & inhibitors</p></td>
|
|
<td><p>Purinergic P2X Receptor Antagonists</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Receptors, Purinergic P2X1/agonists</p></td>
|
|
<td><p>Purinergic P2X Receptor Agonists</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Receptors, Purinergic P2X1/antagonists & inhibitors</p></td>
|
|
<td><p>Purinergic P2X Receptor Antagonists</p></td>
|
|
</tr>
|
|
|
|
<tr>
|
|
<td><p>Receptors, Purinergic P2X2/agonists</p></td>
|
|
<td><p>Purinergic P2X Receptor Agonists</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Receptors, Purinergic P2X2/antagonists & inhibitors</p></td>
|
|
<td><p>Purinergic P2X Receptor Antagonists</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Receptors, Purinergic P2X3/agonists</p></td>
|
|
<td><p>Purinergic P2X Receptor Agonists</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Receptors, Purinergic P2X3/antagonists & inhibitors</p></td>
|
|
<td><p>Purinergic P2X Receptor Antagonists</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Receptors, Purinergic P2X4/agonists</p></td>
|
|
<td><p>Purinergic P2X Receptor Agonists</p></td>
|
|
</tr>
|
|
|
|
<tr>
|
|
<td><p>Receptors, Purinergic P2X4/antagonists & inhibitors</p></td>
|
|
<td><p>Purinergic P2X Receptor Antagonists</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Receptors, Purinergic P2X5/agonists</p></td>
|
|
<td><p>Purinergic P2X Receptor Agonists</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Receptors, Purinergic P2X5/antagonists & inhibitors</p></td>
|
|
<td><p>Purinergic P2X Receptor Antagonists</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Receptors, Purinergic P2X7/agonists</p></td>
|
|
<td><p>Purinergic P2X Receptor Agonists</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Receptors, Purinergic P2X7/antagonists & inhibitors</p></td>
|
|
<td><p>Purinergic P2X Receptor Antagonists</p></td>
|
|
</tr>
|
|
|
|
<tr>
|
|
<td><p>Receptors, Purinergic P2Y/agonists</p></td>
|
|
<td><p>Purinergic P2Y Receptor Agonists</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Receptors, Purinergic P2Y/antagonists & inhibitors</p></td>
|
|
<td><p>Purinergic P2Y Receptor Antagonists</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Receptors, Purinergic P2Y1/agonists</p></td>
|
|
<td><p>Purinergic P2Y Receptor Agonists</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Receptors, Purinergic P2Y1/antagonists & inhibitors</p></td>
|
|
<td><p>Purinergic P2Y Receptor Antagonists</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Receptors, Purinergic P2Y12/agonists</p></td>
|
|
<td><p>Purinergic P2Y Receptor Agonists</p></td>
|
|
</tr>
|
|
|
|
<tr>
|
|
<td><p>Receptors, Purinergic P2Y12/antagonists & inhibitors</p></td>
|
|
<td><p>Purinergic P2Y Receptor Antagonists</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Receptors, Purinergic P2Y2/agonists</p></td>
|
|
<td><p>Purinergic P2Y Receptor Agonists</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Receptors, Purinergic P2Y2/antagonists & inhibitors</p></td>
|
|
<td><p>Purinergic P2Y Receptor Antagonists</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Receptors, Serotonin, 5-HT1/agonists</p></td>
|
|
<td><p>Serotonin 5-HT1 Receptor Agonists</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Receptors, Serotonin, 5-HT1/antagonists & inhibitors</p></td>
|
|
<td><p>Serotonin 5-HT1 Receptor Antagonists</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Receptors, Serotonin, 5-HT2/agonists</p></td>
|
|
<td><p>Serotonin 5-HT2 Receptor Agonists</p></td>
|
|
</tr>
|
|
|
|
<tr>
|
|
<td><p>Receptors, Serotonin, 5-HT2/antagonists & inhibitors</p></td>
|
|
<td><p>Serotonin 5-HT2 Receptor Antagonists</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Receptors, Serotonin, 5-HT3/agonists</p></td>
|
|
<td><p>Serotonin 5-HT3 Receptor Agonists</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Receptors, Serotonin, 5-HT3/antagonists & inhibitors</p></td>
|
|
<td><p>Serotonin 5-HT3 Receptor Antagonists</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Receptors, Serotonin, 5-HT4/agonists</p></td>
|
|
<td><p>Serotonin 5-HT4 Receptor Agonists</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Receptors, Serotonin, 5-HT4/antagonists & inhibitors</p></td>
|
|
<td><p>Serotonin 5-HT4 Receptor Antagonists</p></td>
|
|
</tr>
|
|
<tr>
|
|
<td><p>Sterol 14-Demethylase/antagonists & inhibitors</p></td>
|
|
<td><p>14-alpha Demethylase Inhibitors</p></td>
|
|
</tr>
|
|
|
|
</table>
|
|
|
|
|
|
|
|
|
|
<p class="authors">
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<img src="../new_tb_graphics/black_pixel.gif" width="450" height="1" alt="" />
|
|
|
|
<!--************************CHANGE CITATION INFORMATION BELOW*****************************-->
|
|
<p class="citation">Revised Entry Combinations Table — 2011. NLM Tech Bull. 2010 Nov-Dec;(377):e12b. </p>
|
|
<!--************************END CITATION INFORMATION**************************************-->
|
|
|
|
</div><!-- end of content -->
|
|
|
|
<div class="header" align="center">
|
|
<div class="shadow_bottom" align="left">
|
|
<div class="shadow_right">
|
|
<div class="shadow_corner">
|
|
<table class="grid" width="100%" border="0" cellpadding="0" cellspacing="0">
|
|
<tr>
|
|
<td>
|
|
|
|
<a href="nd10_umls_uts_beta.html" title="Previous Page">PREVIOUS</a>
|
|
|
|
</td><td>
|
|
<span class="issueDateMenu" >
|
|
2010 NOVEMBER–DECEMBER</span> <span class="issueNum">No. 377</span>
|
|
</td>
|
|
<td class="gridNext">
|
|
|
|
<a href="nd10_medline_data_changes_2011.html" title="Next Article">NEXT</a>
|
|
|
|
</td>
|
|
</tr>
|
|
<tr>
|
|
<td>
|
|
<a href="/pubs/techbull/stay_current.html" class="gridBottomLeft">Stay Current <img src="/pubs/techbull/new_tb_graphics/footer_icons_14h.gif" alt="E-Mail Sign Up"/></a>
|
|
</td><td class="gridBottomRight" colspan="2">
|
|
<a href="../tb.html" class="homeMenu">Home</a>
|
|
<a href="../back_issues.html" class="issuesMenu">Back Issues</a>
|
|
<a href="../new_index.html" class="indexMenu">Indexes</a>
|
|
</td>
|
|
</tr>
|
|
</table>
|
|
</div></div></div></div>
|
|
|
|
<!-- BEGIN NLM FOOTER -->
|
|
<div class="footer">
|
|
<a href="/">National Library of Medicine</a> 8600 Rockville Pike, Bethesda, MD 20894
|
|
<br>
|
|
<a href="//www.nlm.nih.gov/socialmedia/index.html">Connect with NLM</a>,
|
|
<a href="//www.nlm.nih.gov/web_policies.html">Web Policies</a>,
|
|
<a href="//www.nlm.nih.gov/careers/jobopenings.html">Careers</a>,
|
|
<a href="//www.nlm.nih.gov/accessibility.html">Accessibility</a>,
|
|
<a href="//www.usa.gov/">USA.gov</a>,
|
|
<a href="//www.hhs.gov/vulnerability-disclosure-policy/index.html">HHS Vulnerability Disclosure</a>
|
|
<br>
|
|
<a href="//www.nih.gov/">NIH</a>,
|
|
<a href="https://www.hhs.gov/">HHS</a>,
|
|
<a href="//www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office">FOIA</a>,
|
|
<a class="supportLink" href="//support.nlm.nih.gov?from=" target="_blank">NLM Support Center</a>
|
|
</div>
|
|
|
|
</div><!-- body -->
|
|
<!--*****************************Content end*******************************-->
|
|
<script src="//assets.nlm.nih.gov/jquery/jquery-latest.min.js"></script>
|
|
<script src="/scripts/support.js"></script>
|
|
<script src="/core/nlm-notifyExternal/1.0/nlm-notifyExternal.min.js"></script>
|
|
</body>
|
|
</html>
|
|
|
|
|